Shell Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Shell Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,794	Closed	-$1M	–	900
2015 Q1	$1M	Sell	5,794 -3,198	-36%	-$469K	0.02%	625
2014 Q4	$1.03M	Buy	8,992 +1,529	+20%	+$185K	0.02%	689
2014 Q3	$1.17M	Sell	7,463 -10,000	-57%	-$1.45M	0.02%	649
2014 Q2	$2.15M	Buy	+17,463	New	+$1.93M	0.03%	457

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Shell Asset Management's SLXP Position: Q2 2015 in Review

Shell Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 5,794 shares — an estimated $1M sold.

Shell Asset Management first reported a position in SLXP in Q2 2014 and held it in 4 quarters. The position peaked at $2.15M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Shell Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Shell Asset Management sold 5,794 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1M.
Shell Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 4 quarters.
Shell Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $2.15M in Q2 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Shell Asset Management's 13F filing for Q2 2015, filed 30 Jul 2015.